These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16779512)

  • 21. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease.
    Dubick MA; Keen CL; DiSilvestro RA; Eskelson CD; Ireton J; Hunter GC
    Proc Soc Exp Biol Med; 1999 Jan; 220(1):39-45. PubMed ID: 9893167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm.
    Eugster T; Huber A; Obeid T; Schwegler I; Gürke L; Stierli P
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):378-82. PubMed ID: 15749038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm.
    Muehling B; Oberhuber A; Schelzig H; Bischoff G; Marx N; Sunder-Plassmann L; Orend KH
    Vasc Health Risk Manag; 2008; 4(6):1433-7. PubMed ID: 19337556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgery of abdominal aorta with horseshoe kidney].
    Lotina SL; Davidović LB; Kostić DM; Velimirović DV; Petrović PLj; Perisić-Savić MV; KovacevićN S
    Srp Arh Celok Lek; 1997; 125(1-2):36-44. PubMed ID: 17974353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
    Nakamura E; Akashi H; Hiromatsu S; Tanaka A; Onitsuka S; Aoyagi S
    Kurume Med J; 2009; 56(1-2):25-32. PubMed ID: 20103998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.
    Grzela T; Brawura-Biskupski-Samaha R; Jelenska MM; Szmidt J
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):159-61. PubMed ID: 17964826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.
    Elmore JR; Keister BF; Franklin DP; Youkey JR; Carey DJ
    Ann Vasc Surg; 1998 May; 12(3):221-8. PubMed ID: 9588507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.
    Eliason JL; Hannawa KK; Ailawadi G; Sinha I; Ford JW; Deogracias MP; Roelofs KJ; Woodrum DT; Ennis TL; Henke PK; Stanley JC; Thompson RW; Upchurch GR
    Circulation; 2005 Jul; 112(2):232-40. PubMed ID: 16009808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysms.
    Tsarouhas K; Tsitsimpikou C; Apostolakis S; Haliassos A; Tzardi M; Panagiotou M; Tsatsakis A; Spandidos DA
    Thromb Res; 2011 Nov; 128(5):e95-9. PubMed ID: 21802713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe structural damage of the seemingly non-diseased infrarenal aortic aneurysm neck.
    Diehm N; Di Santo S; Schaffner T; Schmidli J; Völzmann J; Jüni P; Baumgartner I; Kalka C
    J Vasc Surg; 2008 Aug; 48(2):425-34. PubMed ID: 18502079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases.
    Knox JB; Sukhova GK; Whittemore AD; Libby P
    Circulation; 1997 Jan; 95(1):205-12. PubMed ID: 8994438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.
    Wilson WR; Choke EC; Dawson J; Loftus IM; Thompson MM
    Vascular; 2008; 16(5):248-52. PubMed ID: 19238864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms.
    Monaco M; Stassano P; Di Tommaso L; Iannelli G
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):925-31. PubMed ID: 17903509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Matrix Metalloproteinases and Endogenous Inhibitors in Abdominal Aortic Aneurysm and Aortoiliac Occlusive Disease (Syndrome Leriche).
    Vasic N; Glumac S; Pejic S; Amidzic LJ; Tadic Latinovic LJ; Dozic B; Hinic S; Maksimovic Z
    Folia Biol (Praha); 2017; 63(5-6):209-216. PubMed ID: 29687775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.
    Baxter BT; Pearce WH; Waltke EA; Littooy FN; Hallett JW; Kent KC; Upchurch GR; Chaikof EL; Mills JL; Fleckten B; Longo GM; Lee JK; Thompson RW
    J Vasc Surg; 2002 Jul; 36(1):1-12. PubMed ID: 12096249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture.
    Petersen E; Wågberg F; Angquist KA
    Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):153-7. PubMed ID: 11863333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Size matters: the relationship between MMP-9 expression and aortic diameter.
    McMillan WD; Tamarina NA; Cipollone M; Johnson DA; Parker MA; Pearce WH
    Circulation; 1997 Oct; 96(7):2228-32. PubMed ID: 9337194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incisional hernia postrepair of abdominal aortic occlusive and aneurysmal disease: five-year incidence.
    Alnassar S; Bawahab M; Abdoh A; Guzman R; Al Tuwaijiri T; Louridas G
    Vascular; 2012 Oct; 20(5):273-7. PubMed ID: 22983541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
    Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
    J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic disease.
    Gonzalez-Hidalgo C; De Haro J; Bleda S; Cañibano C; Michel I; Acin F
    Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):123-129. PubMed ID: 29528779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.